Are you Dr. Krucoff?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 85 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
508 Fulton St Rm A3006
Durham, NC 27705Phone+1 919-620-4467
Summary
- Dr. Mitchell Krucoff, MD is a cardiologist in Durham, North Carolina. He is currently licensed to practice medicine in North Carolina. He is affiliated with Durham Veterans Affairs Medical Center and Duke University Hospital.
Education & Training
- MedStar Health/Georgetown-Washington Hospital CenterFellowship, Cardiovascular Disease, 1983 - 1986
- George Washington UniversityResidency, Internal Medicine, 1980 - 1983
- George Washington University School of Medicine and Health SciencesClass of 1980
Certifications & Licensure
- NC State Medical License 1988 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II) Start of enrollment: 2005 May 01
- HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt Start of enrollment: 2014 Feb 01
- LEADERS FREE II: BioFreedom™ Pivotal Study Start of enrollment: 2017 Feb 14
- Join now to see all
Publications & Presentations
PubMed
- 103 citationsTicagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACSUsman Baber, George Dangas, Dominick J. Angiolillo, David J. Cohen, Samin K. Sharma
European Heart Journal. 2020-10-01 - 57 citationsTicagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.Javier Escaned, Davide Cao, Usman Baber, Johny Nicolas, Samantha Sartori
European Heart Journal. 2021-12-01 - 594 citationsTicagrelor with or without Aspirin in High-Risk Patients after PCIRoxana Mehran, Usman Baber, Samin K Sharma, David J. Cohen, Dominick J. Angiolillo
The New England Journal of Medicine. 2019-09-26
Press Mentions
- New Data Registry Collects Evidence in Cardiogenic Shock PatientsOctober 19th, 2022
- Another Study Finds No Evidence of Increased Long-Term Mortality with Paclitaxel-Coated DevicesOctober 10th, 2019
- PCI Reduces Mortality After STEMI in Older AdultsApril 16th, 2019
- Join now to see all
Professional Memberships
- Member
Other Languages
- French